The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; none of the 15 sources its claims cite is checked for support yet.
Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders
Open accessAbstract
Objective To examine the use of the aromatase inhibitor letrozole with FSH for ovarian stimulation in poor responders undergoing ovarian superovulation and IUI.Design Observational cohort study as a prospective clinical trial in patients with unexplained infertility and a low response to ovarian stimulation with FSH.Setting Two tertiary referral infertility clinics associated with the Reproductive Sciences Division, University of Toronto.Patient(s) Twelve patients with unexplained infertility undergoing IUI who received FSH alone in 25 prior cycles with poor response (less than three dominant follicles).Intervention(s) Patients were offered letrozole, 2.5 mg/day from day 3-7 of the menstrual cycle with FSH (50-225 IU/day) starting on day 5-7. hCG (10,000 IU) was given when two leading follicles were >/=2 cm followed by IUI.Main outcome measure(s) Number of mature follicles (>1.8 cm), FSH dose, endometrial thickness, and pregnancy rate.Result(s) Improved response to FSH stimulation with letrozole co-treatment was evidenced by the significantly lower FSH dose associated with significantly higher number of mature follicles. During letrozole plus FSH stimulation cycles, clinical pregnancy was achieved in three cycles (21%).Conclusion(s) In this preliminary report, we demonstrate a potential benefit of aromatase inhibition for improving ovarian response to FSH in poor responders.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
In 12 poor responders with unexplained infertility, adding letrozole to FSH improved ovarian response compared with prior FSH-only cycles. Letrozole plus FSH produced more mature follicles, required less FSH, and yielded three clinical pregnancies (21%), with no pregnancies in FSH-only cycles.
Key findings
- Letrozole plus FSH cycles had significantly more mature follicles (>1.8 cm) than FSH-only cycles: 3.3 ± 1.8 vs 1.9 ± 0.6 (P = .003).
- Total FSH per cycle was significantly lower with letrozole plus FSH: 616 ± 454 IU vs 1590 ± 708 IU (P = .0001), and stimulation days were fewer: 6.57 ± 1.95 vs 9 ± 3.42 (P = .026).
- E2 per mature follicle on hCG day was significantly lower with letrozole plus FSH: 626 ± 302 pmol/L vs 1324 ± 485 pmol/L (P = .0001), while E2 on hCG day, endometrial thickness, and LH on hCG day were not significantly different.
- No pregnancies occurred in FSH-only cycles; during letrozole plus FSH cycles, four patients achieved pregnancy, including three clinical pregnancies (21%) and one chemical pregnancy.
Methods
- Observational cohort study conducted as a prospective clinical trial in 12 patients with unexplained infertility and poor response to FSH in at least two prior cycles, defined as fewer than three follicles >1.8 cm on the day of LH surge or hCG administration.
- Patients received FSH alone in 25 prior cycles and letrozole 2.5 mg/day from day 3–7 plus FSH 50–225 IU/day in 14 cycles; hCG 10,000 IU was given when two leading follicles reached >2 cm, followed by IUI.
- Outcomes were compared between 20 completed FSH-only cycles (excluding canceled cycles) and 14 letrozole plus FSH cycles using t-tests with GraphPad Prism Version 3.
Limitations
- The paper states this preliminary report includes a small number of patients and used a nonrandomized, nonplacebo-controlled design.
- The paper states that possible effects of a short course of letrozole on pregnancy outcome are unknown and should be addressed in counseling and pregnancy follow-up.
- The text makes evident that the comparison relies on prior FSH-only cycles rather than concurrent randomized controls, and that five canceled FSH-only cycles were excluded from the outcome comparison.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
12 Own result · 7 Not checked yet · 7 Own interpretation · 2 Own method
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although there was no difference in the level of E 2 on the day of hCG administration, the amount of E per mature follicle was significantly lower with letrozole treatment.”
- Also stated in: § DISCUSSION · plain
“E2/mature follicle on hCG day (pmol/L) 1324 Ϯ 485 626 Ϯ 302 .0001”
- Also stated in: § DISCUSSION · plain
“Letrozole treatment was associated with a significantly lower amount of E per mature follicle but still within phys-iologic levels seen during natural cycles.”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > RESULTS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § DISCUSSION · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Stimulation days/cycle 9 Ϯ 3.42 6.57Ϯ 1.95 .026”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > DISCUSSION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We have preliminary data to support this mechanism of action in the form of increased FSH and LH during letrozole treatment (data not shown).”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > DISCUSSION
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no significant difference between FSH-only or letrozole plus FSH on the day of hCG administration, LH level, or endometrial thickness on the day of hCG administration”
- Also stated in: § DISCUSSION · plain
“Day of hCG administration 11.6 Ϯ 2.27 11.78 Ϯ 0.939 NS”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § DISCUSSION · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During letrozole plus FSH stimulation cycles, clinical pregnancy was achieved in three cycles (21%).”
- Also stated in: § RESULTS · plain
“Three had clinical pregnancies (21%) and one had a chemical pregnancy.”
- Also stated in: § DISCUSSION · plain
“In addition, three clinical pregnancies were achieved in the letrozole and FSH cycles.”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > Abstract
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § RESULTS · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“significantly higher number of mature follicles.”
- Also stated in: § RESULTS · plain
“During FSH plus letrozole stimulation cycles, the mean number of mature follicles was 3.3, which was significantly higher than in the FSH-only stimulation cycles (1.9 follicles).”
- Also stated in: § DISCUSSION · plain
“No. of mature follicles (Ͼ1.8 cm) 1.9 Ϯ 0.6 3.3 Ϯ 1.8 .003”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > Abstract
plaindirectn = 12 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § RESULTS · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“whereas four patients achieved pregnancy during letrozole plus FSH treatment cycles.”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > RESULTS
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although there was no difference in the level of E 2 on the day of hCG administration”
- Also stated in: § DISCUSSION · plain
“E2 on hCG day (pmol/L) 2471 Ϯ 1113 1786 Ϯ 898 NS”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § DISCUSSION · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no significant difference between FSH-only or letrozole plus FSH on the day of hCG administration, LH level, or endometrial thickness on the day of hCG administration indicating the absence of any antiestrogenic effects of letrozole on the endometrium.”
- Also stated in: § DISCUSSION · plain
“Endometrial thickness on hCG day (cm) 0.89 Ϯ 0.1 0.88 Ϯ 0.09 NS”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § DISCUSSION · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Improved response to FSH stimulation with letrozole co-treatment was evidenced by the significantly lower FSH dose associated with significantly higher number of mature follicles.”
- Also stated in: § RESULTS · plain
“The amount of FSH required was significantly lower in the letrozole plus FSH cycles than the FSH-only cycles.”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > Abstract
plaindirectn = 12- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § RESULTS · plain
- Probably not a substantial claim. 3
- It may state two separate claims as one. 4
None of the sources cited for this claim have been checked yet.
In the paper
“In addition, androgen accumulation in the follicle may stimulate insulin-like growth factor I (IGF-I), and other endocrine and paracrine factors, which may synergize with FSH to promote folliculogenesis (29 -31).”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > DISCUSSION
What the sources say
- Not checked yetcites [29] Adashi, 1993, Intraovarian regulation, Ann NY Acad Sci source
- Not checked yetcites [30] Giudice, 1992, Insulin-like growth factors and ovarian follicular development, Endocr Rev
- Not checked yetcites [31] Yen, 1993, Interface between extra- and intra-ovarian factors in polycystic ovary syndrome (PCOS), Ann NY Acad Sci source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“Markedly elevated E levels have been reported to have deleterious effects on the embryo or the endometrium and jeopardize the chance of achieving pregnancy (32,33).”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > DISCUSSION
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“We have reported the success of aromatase inhibition by letrozole in inducing ovulation in anovulatory women with polycystic ovary syndrome (PCOS) (11)(12)(13)(14) and augmenting ovulation in ovulatory women (13,14).”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > Abstract
What the sources say
- Not checked yetcites [11] Mitwally, 2000, The use of an aromatase inhibitor for induction of ovulation in cases of clomiphene citrate failure
- Not checked yetcites [12] Mitwally, 2000, Aromatase inhibition, Reprod Technol
- Not checked yetcites [13] Mitwally, 2000, The aromatase inhibitor, letrozole: a promising alternative for clomiphene citrate for induction of ovulation
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Aromatase is a cytochrome P-450 enzyme complex that catalyzes the rate-limiting step in the production of estrogens (E), that is, the conversion of the androgens, androstenedione and testosterone, to estrone (E 1 ) and E 2 (9).”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > Abstract
What the sources say
- Not checked yetcites [9] Akhtar, 1993, Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes, J Steroid Biochem Mol Biol source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“This preliminary clinical report includes a small number of patients treated in a nonrandomized, nonplacebo controlled design.”
§ Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders > DISCUSSION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
The paper relies on this without support.
The prior FSH-only cycles and the letrozole+FSH cycles are comparable enough that the observed differences in ovarian response can be attributed to letrozole.
“This preliminary clinical report includes a small number of patients treated in a nonrandomized, nonplacebo controlled design.”
The paper relies on this without support.
Multiple follicle development during gonadotropin stimulation correlates positively with pregnancy outcome.
“Achievement of multiple follicle development during gonadotropin stimulation has been found to correlate positively with the outcome of infertility management in terms of achievement of pregnancy.”
The paper relies on this without support.
Endometrial thickness on the day of hCG administration is a valid marker of antiestrogenic effects of letrozole on the endometrium.
“There was no significant difference between FSH-only or letrozole plus FSH on the day of hCG administration, LH level, or endometrial thickness on the day of hCG administration indicating the absence of any antiestrogenic effects of letrozole on the endometrium.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, it was suggested that letrozole, a specific reversible, nonsteroidal aromatase inhibitor that suppresses estrogen biosynthesis (16), can successfully replace clomiphene citrate in superovulation treatment of patients with unexplained infertility or polycystic ovarian disease and in poor responders (17,18).”
From Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination (2003) · cites this paper as [18]
In the citing paper
“This is in agreement with the previous report (19) that letrozole improves ovarian response to FSH in poor responder women.”
From A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation (2004) · cites this paper as [19]
Citations
Cites
Mitwally, M. F. M., & Casper, R. F. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01705-2 · Cited by 800
Self-citationAndrogens stimulate early stages of follicular growth in the primate ovary
Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J., & Bondy, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2081 · Cited by 712
Androgen and follicle stimulating hormone interactions in primate ovarian follicle development
Weil, S., Vendola, K., Zhou, J., & Bondy, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5929 · Cited by 592
Insulin-Like Growth Factors and Ovarian Follicular Development*
Giudice, L. C. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-4-641 · Cited by 521
Efficacy of Superovulation and Intrauterine Insemination in the Treatment of Infertility
Guzick, D. S., Carson, S. A., Coutifaris, C., Overstreet, J. W., Factor-Litvak, P. R., Steinkampf, M. P., Hill, J. A., Mastroianni, L., Buster, J. E., Nakajima, S. T., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400302 · Cited by 521
Toner, J. P., Philput, C. B., Jones, G. S., & Muasher, S. J. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54249-6 · Cited by 495
Weil, S. J., Vendola, K., Zhou, J., Adesanya, O. O., Wang, J., Okafor, J., & Bondy, C. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4917 · Cited by 359
Vendola, K., Zhou, J., Wang, J., Famuyiwa, O. A., Bievre, M., & Bondy, C. A. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.2.353 · Cited by 324
Assisted conception following poor ovarian response to gonadotrophin stimulation
Keay, S. D., Liversedge, N., Mathur, R., & Jenkins, J. M. (1997) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb11525.x · Cited by 241
Cantab, M. D. (1972) · PubMed · Cited by 222
Research works printed but not linked: 2
- Mitwally, 2000, Aromatase inhibition, Reprod Technol, 10, 244
- Russell, 1995, Pre-cycle estrogen treatment and poor responders, Assist Reprod Rev, 5, 82
Cited by
Sorted by citations
Fertility preservation in female patients
Sönmezer, M. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh021 · Cited by 495
Goswami, S. K. (2004) · Human Reproduction · doi:10.1093/humrep/deh359 · Cited by 372
Mitwally, M. F. M. (2003) · Human Reproduction · doi:10.1093/humrep/deg311 · Cited by 344
Self-citationClomiphene citrate—end of an era? a mini-review
Homburg, R. (2005) · Human Reproduction · doi:10.1093/humrep/dei042 · Cited by 332
Aromatase Inhibitors for Ovulation Induction
Casper, R. F., & Mitwally, M. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1923 · Cited by 272
Self-citationSingle-dose administration of an aromatase inhibitor for ovarian stimulation
Mitwally, M. F., & Casper, R. F. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.952 · Cited by 272
Self-citationGarcía-Velasco, J. A., Moreno, L., Pacheco, A., Guillén, A., Duque, L. A. A., Requena, A., & Pellicer, A. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.01.117 · Cited by 263
Fertility Preservation in Young Women Undergoing Breast Cancer Therapy
Sönmezer, M., & Oktay, K. (2006) · The Oncologist · doi:10.1634/theoncologist.11-5-422 · Cited by 261
Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study
Fatemi, H. M., Kolibianakis, E. M., Tournaye, H. J., Camus, M., Steirteghem, A. V., & Devroey, P. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62070-6 · Cited by 253
Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF
Barad, D. H., & Gleicher, N. (2006) · Human Reproduction · doi:10.1093/humrep/del254 · Cited by 224
Barad, D., Brill, H., & Gleicher, N. (2007) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-007-9178-x · Cited by 207
A new era in ovulation induction
Holzer, H., Casper, R., & Tulandi, T. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.05.078 · Cited by 194
Self-citationPregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation
Mitwally, M. F., Biljan, M. M., & Casper, R. F. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.08.013 · Cited by 186
Self-citationAromatase inhibitors: the next generation of therapeutics for endometriosis?
Attar, E., & Bulun, S. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.064 · Cited by 184
Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation
Mitwally, M. F., & Casper, R. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03975-4 · Cited by 178
Self-citationA randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation
Al-Fozan, H., Al-Khadouri, M., Tan, S. L., & Tulandi, T. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.04.070 · Cited by 174
Cantineau, A. E., & Cohlen, B. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005356.pub2 · Cited by 161
Bosdou, J. K., Venetis, C. A., Kolibianakis, E. M., Toulis, K. A., Goulis, D. G., Zepiridis, L., & Tarlatzis, B. C. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr051 · Cited by 141
Badawy, A., Aal, I. A., & Abulatta, M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.02.062 · Cited by 133
RetractedHealey, S., Tan, S. L., Tulandi, T., & Biljan, M. M. (2003) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.03.001 · Cited by 132
Aromatase inhibitors for the treatment of infertility
Mitwally, M. F., & Casper, R. F. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.3.353 · Cited by 120
Self-citationAndrogens and ovarian function: translation from basic discovery research to clinical impact
Walters, K. A., Rodriguez Paris, V, Aflatounian, A., & Handelsman, D. J. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0096 · Cited by 104
Begum, M. R., Ferdous, J., Begum, A., & Quadir, E. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.08.044 · Cited by 109
Schoolcraft, W. B., Surrey, E. S., Minjarez, D. A., Stevens, J. M., & Gardner, D. K. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.02.013 · Cited by 103
Bayar, Ü., Başaran, M., Kıran, S., Coşkun, A., & Gezer, Ş. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.04.026 · Cited by 100
Assisted Reproductive Techniques
Huang, J. Y. J., & Rosenwaks, Z. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0659-8_8 · Cited by 104
Balasch, J., Fábregues, F., Peñarrubia, J., Carmona, F., Casamitjana, R., Creus, M. T., Manau, D., Casals, G., & Vanrell, J. A. (2006) · Human Reproduction · doi:10.1093/humrep/del052 · Cited by 98
Sohrabvand, F., Ansari, S., & Bagheri, M. (2006) · Human Reproduction · doi:10.1093/humrep/del020 · Cited by 97
Pirard, C., Donnez, J., & Loumaye, E. (2005) · Human Reproduction · doi:10.1093/humrep/deh830 · Cited by 96
Letrozole vs. clomiphene citrate in patients with ovulatory infertility
Bayar, Ü., Tanriverdi, H. A., Barut, A., Ayoğlu, F. N., Özcan, O., & Kaya, E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.045 · Cited by 93
Cortínez, A., Carvalho, I. D., Vantman, D., Gabler, F., Íñiguez, G., & Vega, M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.05.099 · Cited by 92
Roy, K., Baruah, J., Singla, S., Sharma, J., Singh, N., Jain, S. K., & Goyal, M. (2012) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.97789 · Cited by 95
Badawy, A., Shokeir, T. A., ALLAM, A. F., & Abdel‐Hady, H. (2008) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340802638199 · Cited by 90
Aromatase inhibitors in ovulation induction
(2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-823028 · Cited by 87
Self-citationMitwally, M. F., Bhakoo, H. S., Crickard, K., Sullivan, M. W., Batt, R. E., & Yeh, J. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.086 · Cited by 87
Self-citationSuccessful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor
Shippen, E., & West, W. J. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.11.027 · Cited by 85
A randomized trial of superovulation with two different doses of letrozole
Al-Fadhli, R., Sylvestre, C. V., Buckett, W. M., Tan, S. L., & Tulandi, T. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.07.1283 · Cited by 84
Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols
Özmen, B., Sönmezer, M., Atabekoğlu, C. S., & Olmuş, H. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.05.007 · Cited by 82
Dowsett, M., & Haynes, B. P. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00365-0 · Cited by 79
Letrozole for Female Infertility
Yang, A.-M., Cui, N., Sun, Y., & Hao, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.676133 · Cited by 89
Baştu, E., Buyru, F., Özsürmeli, M., Demiral, İ., Doğan, M., & Yeh, J. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.05.027 · Cited by 79
Badawy, A., Mosbah, A., & Shady, M. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.010 · Cited by 76
RetractedLetrozole: Pharmacology, toxicity and potential therapeutic effects
Mukherjee, A. G., Wanjari, U. R., Nagarajan, D., Vibhaa, K. K., Anagha, V., Joshua Paul, P., Thirumoorthy, T. P., Chakraborty, R., Renu, K., Dey, A., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121074 · Cited by 81
Treatment strategies for endometriosis
Rodgers, A. K., & Falcone, T. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.2.243 · Cited by 72
Letrozole for ovulation induction and controlled ovarian hyperstimulation
Pritts, E. A. (2010) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32833beebf · Cited by 76
Ebert, A. D., Bartley, J., & David, M. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.04.017 · Cited by 73
Sunkara, S. K., Pundir, J., & Khalaf, Y. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.01.015 · Cited by 66
Letrozole: ovulation or superovulation?
Casper, R. F. (2003) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.05.004 · Cited by 64
Self-citationQin, Y., Zhao, Z., Sun, M., Geng, L., Che, L., & Chen, Z.-J. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-9 · Cited by 63
González-Comadran, M., Durán, M., Solà, I., Fábregues, F., Carreras, R., & Checa, M. Á. (2012) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2012.07.011 · Cited by 63
Biomaterials for Dental Implants: An Overview
Amarnath, G. S., Muddugangadhar, B. C., Tripathi, S., Suchismita, D., & Divya, M. S. (2011) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1030 · Cited by 62
Mohsen, I. A., & Din, R. E. E. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.730569 · Cited by 59
Poor responder protocols for in-vitro fertilization: options and results
Loutradis, D., Vomvolaki, E., & Drakakis, P. (2008) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328305b9b8 · Cited by 59
Aromatase inhibitors: possible future applications
Karaer, Ö., Oruç, S., & Koyuncu, F. M. (2004) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2004.00562.x · Cited by 59
McClamrock, H. D., Jones, H. W., & Adashi, E. Y. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.02.031 · Cited by 58
Aromatase inhibitors for female infertility: a systematic review of the literature
Polyzos, N. P., Tzioras, S., Badawy, A., Valachis, A., Dritsas, C., & Mauri, D. N. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.06.008 · Cited by 57
Davar, R., Oskouian, H., Ahmadi, S., & Firouzabadi, R. D. (2010) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(10)60064-2 · Cited by 55
Mitwally, M. F., Casper, R. F., & Diamond, M. P. (2005) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-3-54 · Cited by 55
Self-citationGregoriou, O., Vlahos, N., Konidaris, S., Papadias, K., Botsis, D. S., & Creatsas, G. K. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.099 · Cited by 54
Barroso, G., Menocal, G., Felix, H., Ruiz, J. C. R., Arslan, M., & Oehninger, S. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.044 · Cited by 53
Haas, J., Zilberberg, E., Nahum, R., Sason, A. M., Hourvitz, A., Gat, I., & Orvieto, R. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1576621 · Cited by 52
Polycystic ovaries and infertility: Our experience
Rajashekar, L., Krishna, D., & Patil, M. (2008) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.44113 · Cited by 53
Okman, T. K., Küçük, M., & Altaner, Ş. (2003) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.05.002 · Cited by 50
Gat, I., Mejía, S. B., Bałakier, H., Librach, C. L., Claessens, A., & Ryan, E. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1137095 · Cited by 46
The Conundrum of Poor Ovarian Response: From Diagnosis to Treatment
Giannelou, P., Simopoulou, M., Grigoriadis, S., Makrakis, E., Kontogeorgi, A., Pantou, A., Galatis, D. G., Kalampokas, T., Bakas, P., Bolaris, S., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10090687 · Cited by 45
Lee, V. C. Y., Chan, C. C. W., Ng, E. H. Y., Yeung, W. S. B., & Ho, P. C. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.05.012 · Cited by 44
Kedem, A., Tsur, A., Haas, J., Yerushalmi, G., Hourvitz, A., Machtinger, R., & Orvieto, R. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.036 · Cited by 43
Aromatase inhibitors for ovulation induction and ovarian stimulation
Lee, V. C. Y., & Ledger, W. J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04006.x · Cited by 42
Orvieto, R., Kruchkovich, J., Rabinson, J., Zohav, E., Anteby, E. Y., & Meltcer, S. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.022 · Cited by 42
Youssef, M. A. F. M., van Wely, M., Mochtar, M. H., Fouda, U. M., ElDaly, A. A., Abidin, E. Z. E., Elhalwagy, A., Abdallah, A. A. M., Zaki, S. S., Ghafar, M. S. A., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.10.033 · Cited by 42
Different ovarian stimulation protocols for women with diminished ovarian reserve
Loutradis, D., Drakakis, P., Vomvolaki, E., & Antsaklis, A. (2007) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-007-9181-2 · Cited by 42
Mitwally, M. F., Abdel‐Razeq, S. S., & Casper, R. F. (2004) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-2-55 · Cited by 42
Self-citationMisoprostol With or Without Letrozole Pretreatment for Termination of Pregnancy
Lee, V. C. Y., Ng, E. H. Y., Yeung, W. S. B., & Ho, P. C. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182073fbf · Cited by 41
Haas, J., Bassil, R., Meriano, J., Samara, N., Barzilay, E., Gonen, N., & Casper, R. F. (2017) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-017-0288-8 · Cited by 38
Self-citationEruption Chronology in Children: A Cross-sectional Study
Verma, N., Bansal, A., Tyagi, P., Jain, A., Tiwari, U., & Gupta, R. (2017) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1450 · Cited by 40
Surface Modifications for Endosseous Dental Implants
Shetty, O. K., Parekh, R., & Tabassum, R. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1078 · Cited by 38
Shahin, A. Y., & Mohammed, S. A. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.895983 · Cited by 37
Patient-tailored conventional ovulation induction algorithms in anovulatory infertility
van Santbrink, E. J. P., Eijkemans, M. J. C., Laven, J. S. E., & Fauser, B. C. J. M. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.08.006 · Cited by 36
Ebrahimi, M., Akbari-Asbagh, F., & Ghalandar-Attar, M. (2017) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.15.2.101 · Cited by 35
Managing and Predicting Low Response to Standard In Vitro Fertilization Therapy
Karande, V. C. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302040-00004 · Cited by 35
Mukherjee, S., Sharma, S., & Chakravarty, B. (2012) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.101014 · Cited by 34
Thakur, S., & Habib, R. (2017) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1442 · Cited by 33
Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination
Baysoy, A., Serdaroğlu, H., Jamal, H., Karatekeli, E., Özörnek, H., & Attar, E. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60617-7 · Cited by 33
Badawy, A., Aal, I. A., & Abulatta, M. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.08.034 · Cited by 34
RetractedDehbashi, S., Dehbashi, S., Kazerooni, T., Robati, M., Alborzi, S., & Shadman, A. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 32
Fertility preservation in female cancer survivors
Yap, J. K. W., & Davies, M. C. (2007) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610701327412 · Cited by 30
Potential of Aromatase Inhibitors for Ovulation and Superovulation Induction in Infertile Women
Mitwally, M. F., & Casper, R. F. (2006) · Drugs · doi:10.2165/00003495-200666170-00001 · Cited by 29
Self-citationTechniques for fertility preservation in patients with breast cancer
Dunn, L. A., & Fox, K. R. (2009) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32831e13b9 · Cited by 29
Shapira, M., Orvieto, R., Lebovitz, O., Nahum, R., Aizer, A., Segev-Zahav, A., & Haas, J. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00666-z · Cited by 27
Evolution of External and Internal Implant to Abutment Connection
Prithviraj, D., & Muley, N. (2012) · International Journal of Oral Implantology and Clinical Research · doi:10.5005/jp-journals-10012-1079 · Cited by 27
Prajapati, D., Nayak, R., Pai, D., Upadhya, N., Bhaskar, V., & Kamath, P. (2017) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1445 · Cited by 27
Loutradis, D., Drakakis, P., Milingos, S., Stefanidis, K., & Michalas, S. S. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.013 · Cited by 27
Suma, N. (2017) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1440 · Cited by 25
Begum, M. R., Quadir, E., Begum, A., Begum, R. A., & Begum, M. (2006) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2006.00434.x · Cited by 23
Tredway, D. R., Schertz, J. C., Bock, D., Hemsey, G., & Diamond, M. P. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.064 · Cited by 23
Haas, J., Zilberberg, E., Machtinger, R., Kedem, A., Hourvitz, A., & Orvieto, R. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.959919 · Cited by 23
Özcan, P., Fıçıcıoğlu, C., Kızılkale, Ö., Bostancı, M. S., Bakacak, M., Yeşiladalı, M., & Kaspar, Ç. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.893571 · Cited by 22
Lee, K., Kim, C., Suk, H.-J., Lee, Y., Kwon, S.-K., Kim, S.-H., Chae, H., & Kang, B. (2014) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2014.57.3.216 · Cited by 20
Badawy, A., Elnashar, A. M., & Totongy, M. (2010) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2010.497873 · Cited by 22
RetractedBedaiwy, M. A., Shokry, M., Mousa, N. A., Claessens, A., Esfandiari, N., Gotleib, L., & Casper, R. F. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.020 · Cited by 22
Self-citation
Metadata
- Authors
- Mitwally, M. F. M., & Casper, R. F.
- Affiliations
- Mount Sinai Hospital (CA)
- Corresponding author
- Casper, Robert F
- ORCID
- Casper, Robert F
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 77
- Issue
- 4
- Pages
- 776-780
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2023963334
- Semantic Scholar
- c28960882fbca4247ecf3e0ab20c305b14652355
- Cited by
- 407
- References
- 30
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 6 · 2017: 36 · 2016: 11 · 2015: 42 · 2014: 45 · 2013: 30 · 2012: 41
- FWCI
- 13.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- aromatase inhibitors, letrozole, poor ovarian responders, follicle-stimulating hormone, ovulation induction, superovulation, intrauterine insemination, unexplained infertility, clinical pregnancy rate
- MeSH terms
- Letrozole, Endometrium, Enzyme Inhibitors, Estradiol, Female, Follicle Stimulating Hormone, Chorionic Gonadotropin, Ovarian Follicle, Humans, Insemination, Artificial, Menstrual Cycle, Nitriles, Ovulation Induction, Pregnancy, Prospective Studies, Triazoles, Cohort Studies, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
